Syndax Pharmaceuticals Inc Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Syndax Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q2 2024.
  • Syndax Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $9.9M, a 22.7% increase year-over-year.
  • Syndax Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $35.4M, a 54.7% increase year-over-year.
  • Syndax Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2023 was $31M, a 93.2% increase from 2022.
  • Syndax Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $16M, a 20.3% increase from 2021.
  • Syndax Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $13.3M, a 47% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $35.4M $9.9M +$1.83M +22.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $33.6M $8.9M +$2.66M +42.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $31M $8.33M +$4.09M +96.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $26.9M $8.32M +$3.96M +90.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $22.9M $8.07M +$4.13M +105% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $18.8M $6.24M +$2.76M +79.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $16M $4.24M +$312K +7.94% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $15.7M $4.36M +$981K +29% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $14.7M $3.94M +$698K +21.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $14M $3.48M +$711K +25.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $13.3M $3.93M +$1.89M +93% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $11.4M $3.38M +$318K +10.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $11.1M $3.24M +$1.11M +52.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $10M $2.77M +$938K +51.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $9.06M $2.04M +$511K +33.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $8.55M $3.06M +$1.51M +97.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $7.03M $2.13M +$791K +59.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $6.24M $1.83M +$237K +14.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $6.01M $1.53M +$52K +3.53% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $5.95M $1.55M -$187K -10.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $6.14M $1.34M -$232K -14.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $6.37M $1.59M +$171K +12% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $6.2M $1.47M +$194K +15.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 $6.01M $1.74M +$391K +29% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $5.62M $1.57M +$122K +8.43% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $5.49M $1.42M +$44K +3.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $5.45M $1.28M +$332K +35.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 $5.12M $1.35M +$554K +69.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $4.56M $1.45M +$669K +85.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $3.9M $1.38M -$813K -37.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $4.71M $947K -$223K -19.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 $4.93M $792K -$496K -38.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $5.43M $779K -$321K -29.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $5.75M $2.19M +$1.87M +576% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $3.88M $1.17M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 $1.29M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $1.1M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $324K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.